Using advanced single-nuclei RNA sequencing (snRNA-seq) and a widely used preclinical model for Alzheimer's disease, ...

Taking inspiration from the CAR T-cell technology used to provide personalized cancer treatments, researchers have conducted ...

Statins, long hailed for lowering cholesterol, might offer an unexpected benefit beyond heart health—they could help slow ...

A new large-scale study has mapped the first molecular events that drive the formation of harmful amyloid protein aggregates ...

Mayo Clinic researchers validated an FDA-approved blood test that diagnoses Alzheimer’s disease with 95% sensitivity and 82% ...

By analyzing thousands of Aβ42 peptides, the scientists gained a better understanding of how mutations in Aβ affect protein ...

An alarming number of Canadians—over 414—are diagnosed each day with Alzheimer’s or another form of dementia.¹ By 2050, this could […] ...

I wonder if the politicians who voted for the NIH budget know anyone affected by Alzheimer’s or what it’s like to lose someone to dementia.

Volume 17, Issue 5, on May 3, 2025, titled "APOE genotype and biological age impact inter-omic associations related to ...

Cobenfy, the novel antipsychotic drug that Bristol Myers Squibb obtained from a $14 billion acquisition, could have a problem ...

Cognito Therapeutics today announced new study results showing that its Spectris AD therapy significantly slows Alzheimer's ...

Using advanced single-nuclei RNA sequencing (snRNA-seq) and a widely used preclinical model for Alzheimer's disease, ...